Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period
Nilesh Jethwa, Founder and CEO at InfoCaptor (Rudrasoft), shared a post on X:
“The adverse event reports for Yasmin cover a total of 23,442 reports, with data spanning from July 2024 to June 2026.
The most frequently reported adverse events include pain (8,582 reports), injury (7,481 reports), pulmonary embolism (5,614 reports), and deep vein thrombosis (5,406 reports).
Among the reported outcomes, 219 cases were classified as fatal, while the majority of reports indicated recovery or ongoing recovery.
Serious reactions frequently included pain, injury, pulmonary embolism, and deep vein thrombosis.
The data shows a predominance of reports from females, with 23,230 female reports compared to only 44 from males.
The reporting trend appears to be stable over the observed months.
It is important to note that adverse event reports are spontaneous and voluntary, do not establish causation, may contain duplicates, and cannot be used to calculate true incidence or risk.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 16:24W. Alberto Sifuentes Giraldo: Exploring Peripheral Macrovascular Thrombosis in CAPS
-
Oct 17, 2026, 16:17Rishabh Jain: Could Rusfertide Transform Polycythemia Vera Management?
-
Oct 17, 2026, 16:16Fabrice Cognasse: Advancing Transfusion Medicine Through International Collaboration
-
Oct 17, 2026, 16:10Abdul Muqtadir Abbasi: PNH – How to Interpret Flow Cytometry
-
Oct 17, 2026, 16:10Lakshmi Kattamuri: Contemporary Evidence on Antithrombotic Therapy in AF and Chronic Coronary Disease
-
Oct 17, 2026, 16:05Gregg W. Stone: Short-Term DOACs Show Advantage Over DAPT Post-LAAO
-
Oct 17, 2026, 15:58Cristine Magallanes: Caring Beyond Hospitality – Accor Hosts Community Platelet Donation Drive
-
Oct 17, 2026, 15:57Isaac James: Zoster Vaccine Response in MPN Patients on JAK Inhibitors
-
Oct 17, 2026, 15:51Mohammad Reza Moghaddasnejad: A New Chapter in Cancer Research – Exploring the Role of Platelets in Cancer Metastasis